Inteliview
Log inSign up
Topics

KR Stocks

KOSPI, KOSDAQ, and major corporate filings through a smart money lens.

IMGT Invests $500K in US Subsidiary for FDA Clinical Trial Management

IMGT (456570) announced on May 7, 2026 via DART that it will invest $500,000 (approximately $344K USD equivalent) in IMGT USA, Inc., its 100% subsidiary based in Virginia, to manage FDA-regulated clinical trials and establish direct product distribution and sales channels in the US market.

456570
아이엠지티, 미국 현지법인에 7억 2500만원 투자…자기자본의 27.6% 규모

SungSung E&G Bags $349M Cleanroom Expansion Contract from SEMCNS

SungSung E&G (011930) secured a 50.7 billion won ($349M) cleanroom expansion project for semiconductor parts supplier SEMCNS's facility in Cheongju, North Chungcheong, with construction running May–July 2026.

011930
신성이엔지, 샘씨엔에스 클린룸 증설 공사 507억 수주… 연매출의 0.89%

HD Hyundai Electric Wins $118M U.S. Order for 765kV Ultra-High-Voltage Transformers — 4.2% of Annual Revenue

HD Hyundai Electric has secured a contract to supply 765kV ultra-high-voltage transformers and reactors to a major utility in the MISO and SPP regions of the U.S. through its American subsidiary. The deal is valued at approximately $118M, representing 4.24% of annual revenue.

267260
HD현대일렉트릭, 미국에 765kV 초고압 변압기 1730억 수주… 연매출의 4.2%

S.C. Engineering Secures $192M Cheonan Plant EPC Order from DuPont Korea

S.C. Engineering (023960) has secured a $192M engineering, procurement, and construction (EPC) contract for DuPont Specialty Materials Korea's Cheonan plant, representing 16.2% of its 2025 annual revenue. The project runs from May 2026 through November 2027.

023960
에쓰씨엔지니어링, 듀폰 코리아 천안 공장 EPC 수주 279억…연매출의 16%

Coas Converts $3.4M Convertible Bond to Haesung Optics Stock, Betting 14% of Equity

Coas will convert $3.4M of its $10.3M Haesung Optics convertible bond into equity, securing a 4.13% stake. The acquisition represents 14.40% of Coas's shareholders' equity.

071950
코아스, 해성옵틱스 전환사채 50억 주식 전환… 자기자본의 14% 베팅

Hyosung Chemical to Invest $34.5M in Private Equity Fund — 7.9% of Equity Capital

Hyosung Chemical (298000) has approved a limited partnership investment of $34.5M in Aurora Growth Partnership Fund III, managed by Aurora Partners. The commitment represents 7.9% of the company's equity capital, with funding scheduled for June 8, 2026.

298000
효성화학, 사모펀드에 500억 출자 결정… 자기자본의 7.9% 투입

Jinheung Enterprise Wins $265M Biomedical Cluster Construction Contract from Asan Foundation

Jinheung Enterprise (002780) has secured a 38.47 billion won ($26.5M) construction contract for a biomedical cluster complex in Seoul's Goduck Gangil district from the Asan Social Welfare Foundation, representing 6.67% of the company's projected 2025 revenue.

002780
진흥기업, 아산사회복지재단으로부터 385억 바이오메디컬 클러스터 공사 수주 — 연매출의 6.67%